Table 3.
Factors |
Overall |
Men |
Women |
|||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
Behavioural risk factors | ||||||
Excessive drinkinga | 1125 | 7.5 | 838 | 12.2 | 287 | 3.5 |
Binge drinkingb | 1993 | 13.2 | 1438 | 20.9 | 555 | 6.8 |
<recommended daily fruit intake | 6413 | 42.5 | 3543 | 51.5 | 2870 | 35.0 |
<recommended daily vegetable intake | 7249 | 48.1 | 3747 | 54.5 | 3502 | 42.7 |
Low leisure time physical activityc | 11456 | 76.9 | 4984 | 73.4 | 6472 | 79.9 |
Current smoking | 1977 | 13.1 | 984 | 14.3 | 993 | 12.1 |
Former smoking | 4533 | 30.0 | 2436 | 35.4 | 2097 | 25.5 |
Measured diseases/conditions | ||||||
Obesity (BMI ≥30 kg/m2) | 3463 | 22.9 | 1426 | 20.7 | 2037 | 24.8 |
Overweight (25≤ BMI< 30 kg/m2) | 6072 | 40.2 | 3113 | 45.2 | 2959 | 36.0 |
Hypertensiond | 5402 | 35.8 | 2760 | 40.1 | 2642 | 32.2 |
Pre-hypertensione | 3546 | 23.5 | 2020 | 29.4 | 1526 | 18.6 |
Hypercholesterolaemiaf | 9282 | 61.5 | 4056 | 58.9 | 5226 | 63.6 |
Low HDL-Cg | 2712 | 18.0 | 1009 | 14.7 | 1703 | 20.7 |
Hypertriglyceridaemiah | 4704 | 31.2 | 2813 | 40.9 | 1891 | 23.0 |
Diabetesi | 2969 | 20.0 | 1603 | 23.3 | 1366 | 16.6 |
Impaired fasting glucose, ADAj | 7947 | 52.6 | 4050 | 58.8 | 3897 | 47.4 |
Impaired fasting glucose, WHOk | 2887 | 19.1 | 1680 | 24.4 | 1207 | 14.7 |
Impaired glucose tolerancel | 3066 | 20.3 | 1456 | 21.1 | 1610 | 20.0 |
Elevated hsCRPm | 4229 | 28.0 | 1565 | 22.8 | 2664 | 32.5 |
Elevated UACRn | 736 | 5.0 | 408 | 6.1 | 328 | 4.1 |
Low eGFR (<60 ml/min)o | 681 | 4.6 | 359 | 5.3 | 322 | 4.0 |
Hypothyroidismp | 119 | 0.8 | 49 | 0.7 | 70 | 0.8 |
Chagas disease seropositivity | 115 | 0.8 | 57 | 0.8 | 58 | 0.7 |
Common mental disordersq | 4036 | 26.7 | 1265 | 18.4 | 2771 | 33.7 |
Depression | 637 | 4.2 | 159 | 2.3 | 478 | 5.8 |
Anxiety | 2436 | 16.1 | 762 | 11.1 | 1674 | 20.4 |
Self reported chronic diseases | ||||||
Coronary heart diseaser | 721 | 4.7 | 393 | 5.7 | 328 | 4.0 |
Heart failure | 251 | 1.7 | 128 | 1.9 | 123 | 1.5 |
Stroke | 197 | 1.3 | 90 | 1.3 | 107 | 1.3 |
Rheumatic fevers | 433 | 2.9 | 155 | 2.2 | 278 | 3.4 |
Chagas disease | 64 | 0.4 | 31 | 0.4 | 33 | 0.4 |
Cancert | 695 | 4.6 | 284 | 4.1 | 411 | 5.0 |
Asthma | 1758 | 11.6 | 691 | 10.0 | 1067 | 13.0 |
COPDu | 308 | 2.0 | 124 | 1.8 | 184 | 2.2 |
Cirrhosis or hepatitis | 1303 | 8.6 | 608 | 8.8 | 695 | 8.5 |
Polycystic ovary syndrome | – | – | – | – | 903 | 11.1 |
Small differences in number of participants for each outcome are due to missing values.
aExcessive drinking defined as >210 g alcohol/week for men and 140 g alcohol/week for women.
bDefined as the consumption of 5 or more doses of alcohol in a period of 2 h at least 2–3 times per month over the past 12 months.6
cObtained with the International Physical Activity Questionnaire (IPAQ) – Short Form, and defined according to the IPAC Guidelines for Data Processing and Analysis.7
dDefined as systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg, or verified treatment with anti-hypertensive medication during the past 2 weeks.
eNon-hypertensive participants with systolic blood pressure 120–139 mmHg or diastolic blood pressure 80–89 mmHg.
f>5.17 mmol/l (200 mg/dl).
gMen <1.03 mmol/l (40 mg/dl); women <1.29 mmol/l (50 mg/dl).
h≥1.69 mmol/l (150 mg/dl).
iDefined as a report of a previous diagnosis of diabetes or the use of medication for diabetes, or meeting a diagnostic value for diabetes according to one of the following tests: fasting or 2-h plasma glucose obtained during a 75-g oral glucose tolerance test (OGTT); or HbA1C.
jFasting glucose 5.5–6.9 mmol/l (100–125 mg/dl), American Diabetes Association.
kFasting glucose 6.1–6.9 mmol/l (110–125 mg/dl), World Health Organization.
l2-h glucose 7.8–11.0 mmol/l (140–199 mg/dl).
mHigh sensitivity C-reactive protein ≥28.57 nmol/l (3 mg/dl).
nUrine albumin-to-creatinine ratio ≥3.4 mg/mmol (30 mg/g), from validated overnight collection.
oGlomerular filtration rate estimated by Chronic Kidney Disease Epidemiology Collaboration (CKD-Epi), considering Blacks and Browns as Blacks.
pThyroid-stimulating hormone (TSH) >4.0 mIU/l and thyroxine (T4) <11.6 pmol/l (0.9 ng/dl).
qDefined as a score ≥12 obtained in the Clinical Interview Schedule-Revised (CIS-R).
rMyocardial infarction, coronary revascularization or a physician diagnosis of angina pectoris.
sRheumatic fever/ rheumatic heart disease.
t14.2% (99) of cancers were non-melanoma skin cancer.
uChronic obstructive pulmonary disease.